Charles River Laboratories
CRLNASDAQ·Health Care
Company Overview
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
- Industry
- Life Sciences Tools & Services
Financial Summary
- Revenue (TTM)
- $1.36B
- Net Income (TTM)
- $486.23M
- Total Assets
- $8.20B
- Total Debt
- $1.09B
- Total Equity
- $3.60B
- Market Cap
- -
Valuation Metrics
- P/E Ratio
- -
- P/B Ratio
- -
- Profit Margin
- 35.67%
- ROE
- 13.52%
- ROA
- 5.93%
- Dividend Yield
- -